Global law firm Hogan Lovells has added Ryan Foringer to the firm’s Medical Device and Technology practice as a Senior Regulatory Specialist. In this role, Foringer will assist clients with FDA regulations and policies focused on medical device technology, bringing FDA and private sector experience in developing regulatory strategies, new product development, design controls, quality management systems, clinical study development, and authoring regulatory submissions.

Foringer joins Hogan Lovells from Renew Research, where he served as senior director of regulatory operations for projects focusing on neurological and cardiovascular medical devices. In that position, he led an international, interdisciplinary team in the preparation of FDA regulatory submissions including pre-submissions, breakthrough device designation requests, and de novo submissions. He also advised international affiliates on FDA regulatory matters and compliance. Before joining Renew Research, Foringer served in a similar capacity at Stage 2 Contract Engineering, where he led projects focusing on neurological, cardiovascular, and diabetes devices.

Prior to his work in the private sector, Foringer spent nearly four years at the FDA.  He served as a consumer safety officer in the CFSAN Office of Compliance, as a lead reviewer and chemical engineer in the CDRH Office of Device Evaluation, and as an engineer in the CTP Office of Science. In his time at FDA, he focused on dietary supplement and food labeling compliance, evaluating the safety and effectiveness of regulated medical devices, and evaluating the safety of tobacco products.

Foringer obtained his bachelor’s degree in chemical engineering from Rochester Institute of Technology.